Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention.

Annual review of immunology - 26 Apr 2020

Stephenson Kathryn E, Wagh Kshitij, Korber Bette, Barouch Dan H

Abstract excerpt

Development of improved approaches for HIV-1 prevention will likely be required for a durable end to the global AIDS pandemic. Recent advances in preclinical studies and early phase clinical trials offer renewed promise for immunologic strategies for blocking acquisition of HIV-1 infection. Clinical trials are currently underway to evaluate the efficacy of two vaccine candidates and a broadly neutralizing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS Vaccines
Share to Antibodies, Neutralizing
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Management

Share to HIV Antibodies

Share to Host-Pathogen Interactions

Share to Immunization, Passive

Share to Viral Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 32340576
DOI: 10.1146/annurev-immunol-080219-023629
PMCID: PMC7375352

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention.PMID 32340576Read ↗

Harnessing the protective potential of HIV-1 neutralizing antibodiesSemantic proximity Read ↗

Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application.Semantic proximity Read ↗

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.Semantic proximity Read ↗

The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and PreventionSemantic proximity Read ↗

Progress toward active or passive HIV-1 vaccination.Semantic proximity Read ↗

Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.Semantic proximity Read ↗

Broadly Neutralizing Antibodies for HIV EradicationSemantic proximity Read ↗

A critical question for HIV vaccine development: which antibodies to induce?Semantic proximity Read ↗

HIV-1 vaccine immunogen design strategiesSemantic proximity Read ↗

Catch Me If You Can--The Race Between HIV and Neutralizing Antibodies.Semantic proximity Read ↗

<scp>HIV</scp>‐1 neutralizing antibodies: understanding nature's pathwaysSemantic proximity Read ↗

Virological features associated with the development of broadly neutralizing antibodies to HIV-1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.